&Partners’s Idexx Laboratories IDXX Stock Holding History

&Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.55M	Sell	6,326 -907	-13%	-$582K	0.02%	651
2025 Q4	$4.9M	Buy	7,233 +850	+13%	+$579K	0.03%	504
2025 Q3	$4.08M	Buy	6,383 +456	+8%	+$277K	0.03%	490
2025 Q2	$3.18M	Buy	5,927 +2,839	+92%	+$1.36M	0.02%	491
2025 Q1	$1.28M	Buy	3,088 +1,561	+102%	+$678K	0.01%	724
2024 Q4	$634K	Buy	1,527 +475	+45%	+$208K	0.01%	966
2024 Q3	$531K	Buy	+1,052	New	+$511K	0.01%	841

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

&Partners's IDXX Position: Q1 2026 in Review

&Partners reduced its Idexx Laboratories (IDXX) stake by 13% in Q1 2026, selling an estimated $582K and leaving 6,326 shares worth $3.55M. The position accounts for 0.02% of the portfolio, ranked #651.

&Partners first reported a position in IDXX in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.9M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

&Partners held 6,326 shares of Idexx Laboratories worth $3.55M as of Q1 2026.
&Partners sold 907 Idexx Laboratories shares in Q1 2026, an estimated $582K.
Idexx Laboratories made up 0.02% of &Partners's portfolio in Q1 2026, its #651 holding.
&Partners first reported a position in Idexx Laboratories in Q3 2024 and has held it in 7 quarters since.
&Partners's Idexx Laboratories position peaked at $4.9M in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.